📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MolecularMD

1.1 - Company Overview

MolecularMD Logo

MolecularMD

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty molecular diagnostics products and services for oncology, supporting clinical development and commercialization of cancer therapies. Offers tests to enable appropriate selection, monitoring, and management of patients treated with molecularly targeted cancer therapies, incorporating both gold-standard and innovative assay technologies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MolecularMD

Allegro Diagnostics Logo

Allegro Diagnostics

HQ: United States Website
  • Description: Provider of genomic tests in development to support the diagnosis and management of lung cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allegro Diagnostics company profile →
Imagion Biosystems Logo

Imagion Biosystems

HQ: United States Website
  • Description: Provider of molecularly targeted magnetic nanoparticles (MagSense) for cancer detection, developing imaging agents for solid tumors to aid diagnosis and staging, and conducting a Phase 1 HER2 breast cancer lymph node study aiming to avoid biopsies. Offers PrecisionMRX nanoparticles for MRI, hyperthermia, and magnetic particle imaging; supplies SPIONs with multiple coatings and nanoparticles for third-party biomedical applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imagion Biosystems company profile →
Pionyr Logo

Pionyr

HQ: United States Website
  • Description: Provider of immuno-oncology therapeutics that enhance antitumor immunity by targeting the tumor microenvironment. Utilizes novel target discovery and antibody generation platforms and its Myeloid Tuning approach. Programs include PY314 (TREM2) to deplete tumor-associated macrophages, PY159 (TREM1) to repolarize them to counteract immunosuppression, and PY265 (MARCO) to activate immune responses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pionyr company profile →
ArcherDX Logo

ArcherDX

HQ: United States Website
  • Description: Provider of NGS-based assay solutions advancing molecular pathology, using proprietary Anchored Multiplex PCR (AMP) chemistry and Archer Analysis software to detect genetic mutations for solid tumor, blood cancer, and genetic disease research. Offers VARIANTPlex DNA panels, FUSIONPlex RNA panels, LIQUIDPlex ctDNA panels, IMMUNOVerse immune profiling assays, and an Assay Marketplace for custom NGS panels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ArcherDX company profile →
Algeta Logo

Algeta

HQ: Norway Website
  • Description: Provider of targeted oncology therapies based on an alpha-pharmaceutical platform, including radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Algeta company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MolecularMD

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MolecularMD

2.2 - Growth funds investing in similar companies to MolecularMD

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MolecularMD

4.2 - Public trading comparable groups for MolecularMD

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MolecularMD

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MolecularMD

What does MolecularMD do?

MolecularMD is a provider of specialty molecular diagnostics products and services for oncology, supporting clinical development and commercialization of cancer therapies. Offers tests to enable appropriate selection, monitoring, and management of patients treated with molecularly targeted cancer therapies, incorporating both gold-standard and innovative assay technologies.

Who are MolecularMD's competitors?

MolecularMD's competitors and similar companies include Allegro Diagnostics, Imagion Biosystems, Pionyr, ArcherDX, and Algeta.

Where is MolecularMD headquartered?

MolecularMD is headquartered in United States.

How many employees does MolecularMD have?

MolecularMD has 1,000 employees 🔒.

When was MolecularMD founded?

MolecularMD was founded in 2010 🔒.

What sector and industry vertical is MolecularMD in?

MolecularMD is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MolecularMD

Who are the top strategic acquirers in MolecularMD's sector and industry

Top strategic M&A buyers and acquirers in MolecularMD's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MolecularMD?

Top strategic M&A buyers groups and sectors for MolecularMD include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MolecularMD's sector and industry vertical

Which are the top PE firms investing in MolecularMD's sector and industry vertical?

Top PE firms investing in MolecularMD's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MolecularMD's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MolecularMD's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MolecularMD's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MolecularMD include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MolecularMD's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MolecularMD?

The key public trading comparables and valuation benchmarks for MolecularMD include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MolecularMD for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MolecularMD with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MolecularMD's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MolecularMD with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MolecularMD's' sector and industry vertical?

Access recent funding rounds and capital raises in MolecularMD's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MolecularMD